Samrat Pharmachem
324.85
+6.90(+2.17%)
Market Cap₹98.20 Cr
PE Ratio13.81
IndustryHealthcare
Company Performance:
1D+2.17%
1M-12.34%
6M-6.65%
1Y-16.06%
5Y+221.16%
View Company Insightsright
Latest news about Samrat Pharmachem
Samrat Pharmachem Reappoints Key Executives, Maintaining Family Leadership Jul 25, 2025
Samrat Pharmachem Limited has announced the reappointment of three key executives for five-year terms, effective April 1, 2026, subject to shareholder approval. Lalit Mehta (88) will continue as Chairman & Managing Director, Rajesh Mehta (61) as Executive Director, and Megh Mehta (32) as Executive Director. The reappointments aim to maintain leadership continuity and leverage their extensive industry experience. The board will consist of seven directors, including three executive directors and four independent non-executive directors, balancing family leadership with independent oversight.